Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients

B.S. Kappelhoff, A.D.R. Huitema, K.M.L. Crommentuyn, J.W. Mulder, P.L. Meenhorst, E.C.M van Gorp, A.T.A. Mairuhu, J.H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)174-182
Number of pages9
JournalBritish Journal of Clinical Pharmacology
Volume59
Issue number2
Publication statusPublished - 2005

Cite this